BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33589790)

  • 1. Identification of a sex-stratified genetic algorithm for opioid addiction risk.
    Bright D; Langerveld A; DeVuyst-Miller S; Saadeh C; Choker A; Lehigh E; Wheeler S; Zayzafoon A; Sohn M
    Pharmacogenomics J; 2021 Jun; 21(3):326-335. PubMed ID: 33589790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Variants Associated With Opioid Use Disorder.
    Freiermuth CE; Kisor DF; Lambert J; Braun R; Frey JA; Bachmann DJ; Bischof JJ; Lyons MS; Pantalon MV; Punches BE; Ancona R; Sprague JE
    Clin Pharmacol Ther; 2023 May; 113(5):1089-1095. PubMed ID: 36744646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association analysis of opioid use disorder: A novel approach using clinical data.
    Song W; Kossowsky J; Torous J; Chen CY; Huang H; Mukamal KJ; Berde CB; Bates DW; Wright A
    Drug Alcohol Depend; 2020 Dec; 217():108276. PubMed ID: 32961455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.
    Kaski SW; Brooks S; Wen S; Haut MW; Siderovski DP; Berry JH; Lander LR; Setola V
    J Opioid Manag; 2019; 15(2):103-109. PubMed ID: 31057342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of OPRM1 Functional Coding Variant With Opioid Use Disorder: A Genome-Wide Association Study.
    Zhou H; Rentsch CT; Cheng Z; Kember RL; Nunez YZ; Sherva RM; Tate JP; Dao C; Xu K; Polimanti R; Farrer LA; Justice AC; Kranzler HR; Gelernter J;
    JAMA Psychiatry; 2020 Oct; 77(10):1072-1080. PubMed ID: 32492095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Korean Version of the CAGE-Adapted to Include Drugs Combined With Clinical Predictors to Screen for Opioid-Related Aberrant Behavior.
    Lee CS; Kim D; Park SY; Lee SC; Kim YC; Moon JY
    Anesth Analg; 2019 Sep; 129(3):864-873. PubMed ID: 31425231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review.
    Morris CJ; Mills-Huffnagle S; Zgierska AE
    Brain Res Bull; 2022 Oct; 188():67-76. PubMed ID: 35901984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying risk of opioid use disorder for patients taking opioid medications with deep learning.
    Dong X; Deng J; Rashidian S; Abell-Hart K; Hou W; Rosenthal RN; Saltz M; Saltz JH; Wang F
    J Am Med Inform Assoc; 2021 Jul; 28(8):1683-1693. PubMed ID: 33930132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Performance of a Gene-Based Machine Learning Classifier in Assessing Risk of Developing OUD in Subjects Taking Oral Opioids: A Prospective Observational Study.
    Donaldson K; Cardamone D; Genovese M; Garbely J; Demers L
    Ann Clin Lab Sci; 2021 Jul; 51(4):451-460. PubMed ID: 34452883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The phenomics and genetics of addictive and affective comorbidity in opioid use disorder.
    Freda PJ; Moore JH; Kranzler HR
    Drug Alcohol Depend; 2021 Apr; 221():108602. PubMed ID: 33652377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014.
    Burke LG; Zhou X; Boyle KL; Orav EJ; Bernson D; Hood ME; Land T; Bharel M; Frakt AB
    Addiction; 2020 Mar; 115(3):493-504. PubMed ID: 31691390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of reported NSAID "allergies" on opioid use disorder in back pain.
    Li L; Chang Y; Song S; Losina E; Costenbader KH; Laidlaw TM
    J Allergy Clin Immunol; 2021 Apr; 147(4):1413-1419. PubMed ID: 32916184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use.
    Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Yalçın-Şahiner Ş; Ağtaş-Ertan E; Özgür-İlhan İ
    Eur J Pharmacol; 2022 Apr; 921():174862. PubMed ID: 35271823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs.
    Scott TM; Arnsten J; Olsen JP; Arias F; Cunningham CO; Rivera Mindt M
    Addict Sci Clin Pract; 2021 Oct; 16(1):64. PubMed ID: 34689841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations.
    Anne S; Mims JW; Tunkel DE; Rosenfeld RM; Boisoneau DS; Brenner MJ; Cramer JD; Dickerson D; Finestone SA; Folbe AJ; Galaiya DJ; Messner AH; Paisley A; Sedaghat AR; Stenson KM; Sturm AK; Lambie EM; Dhepyasuwan N; Monjur TM
    Otolaryngol Head Neck Surg; 2021 Apr; 164(2_suppl):S1-S42. PubMed ID: 33822668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a machine learning algorithm for early detection of opioid use disorder.
    Segal Z; Radinsky K; Elad G; Marom G; Beladev M; Lewis M; Ehrenberg B; Gillis P; Korn L; Koren G
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00669. PubMed ID: 33200572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction.
    Levran O; Randesi M; Rotrosen J; Ott J; Adelson M; Kreek MJ
    PLoS One; 2019; 14(11):e0224399. PubMed ID: 31689297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ancestry may confound genetic machine learning: Candidate-gene prediction of opioid use disorder as an example.
    Hatoum AS; Wendt FR; Galimberti M; Polimanti R; Neale B; Kranzler HR; Gelernter J; Edenberg HJ; Agrawal A
    Drug Alcohol Depend; 2021 Dec; 229(Pt B):109115. PubMed ID: 34710714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.